374 related articles for article (PubMed ID: 36519895)
1. Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureus.
Sharma AD; Gutheil WG
Microbiol Spectr; 2023 Feb; 11(1):e0372622. PubMed ID: 36519895
[TBL] [Abstract][Full Text] [Related]
2. Library Screening for Synergistic Combinations of FDA-Approved Drugs and Metabolites with Vancomycin against VanA-Type Vancomycin-Resistant Enterococcus faecium.
Gargvanshi S; Gutheil WG
Microbiol Spectr; 2022 Oct; 10(5):e0141222. PubMed ID: 35969069
[TBL] [Abstract][Full Text] [Related]
3. Analysis of synergy between beta-lactams and anti-methicillin-resistant Staphylococcus aureus agents from the standpoint of strain characteristics and binding action.
Ono D; Yamaguchi T; Hamada M; Sonoda S; Sato A; Aoki K; Kajiwara C; Kimura S; Fujisaki M; Tojo H; Sasaki M; Murakami H; Kato K; Ishii Y; Tateda K
J Infect Chemother; 2019 Apr; 25(4):273-280. PubMed ID: 30713034
[TBL] [Abstract][Full Text] [Related]
4. β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.
Mehta S; Singh C; Plata KB; Chanda PK; Paul A; Riosa S; Rosato RR; Rosato AE
Antimicrob Agents Chemother; 2012 Dec; 56(12):6192-200. PubMed ID: 22985884
[TBL] [Abstract][Full Text] [Related]
5. CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
Tong SY; Nelson J; Paterson DL; Fowler VG; Howden BP; Cheng AC; Chatfield M; Lipman J; Van Hal S; O'Sullivan M; Robinson JO; Yahav D; Lye D; Davis JS;
Trials; 2016 Mar; 17():170. PubMed ID: 27029920
[TBL] [Abstract][Full Text] [Related]
6. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
7. β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA.
Tran N; Rybak MJ
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555635
[TBL] [Abstract][Full Text] [Related]
8. Combinations of cefoxitin plus other β-lactams are synergistic in vitro against community associated methicillin-resistant Staphylococcus aureus.
Banerjee R; Fernandez MG; Enthaler N; Graml C; Greenwood-Quaintance KE; Patel R
Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):827-33. PubMed ID: 23340864
[TBL] [Abstract][Full Text] [Related]
9. Synergistic Antibacterial Activity Between 1,4-Naphthoquinone and β-Lactam Antibiotics Against Methicillin-Resistant
Yap JKY; Tan SYY; Tang SQ; Thien VK; Chan EWL
Microb Drug Resist; 2021 Feb; 27(2):234-240. PubMed ID: 32589487
[No Abstract] [Full Text] [Related]
10. What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant
García Aragonés L; Blanch Sancho JJ; Segura Luque JC; Mateos Rodriguez F; Martínez Alfaro E; Solís García Del Pozo J
Postgrad Med J; 2022 Jan; 98(1155):48-56. PubMed ID: 33563707
[TBL] [Abstract][Full Text] [Related]
11. Sensitizing of β-lactam resistance by tannic acid in methicillin-resistant S. aureus.
Kırmusaoğlu S
World J Microbiol Biotechnol; 2019 Mar; 35(4):57. PubMed ID: 30900046
[TBL] [Abstract][Full Text] [Related]
12. Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in
Lai L-Y; Satishkumar N; Cardozo S; Hemmadi V; Marques LB; Huang L; Filipe SR; Pinho MG; Chambers HF; Chatterjee SS
mBio; 2024 May; 15(5):e0288923. PubMed ID: 38530033
[TBL] [Abstract][Full Text] [Related]
13. Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Fernandez J; Abbanat D; Shang W; He W; Amsler K; Hastings J; Queenan AM; Melton JL; Barron AM; Flamm RK; Lynch AS
Antimicrob Agents Chemother; 2012 Mar; 56(3):1476-84. PubMed ID: 22232278
[TBL] [Abstract][Full Text] [Related]
14. β-Lactam-Induced Cell Envelope Adaptations, Not Solely Enhanced Daptomycin Binding, Underlie Daptomycin-β-Lactam Synergy in Methicillin-Resistant Staphylococcus aureus.
Lew C; Mishra NN; Bayer AS; Rose WE
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0035621. PubMed ID: 34097478
[TBL] [Abstract][Full Text] [Related]
15. Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes.
Barber KE; Werth BJ; Ireland CE; Stone NE; Nonejuie P; Sakoulas G; Pogliano J; Rybak MJ
J Antimicrob Chemother; 2014 Nov; 69(11):3006-10. PubMed ID: 24990867
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin.
Srisrattakarn A; Chaiyapoke C; Booncharoen S; Wongthong S; Chanawong A; Tippayawat P; Tavichakorntrakool R; Lulitanond A
Turk J Med Sci; 2021 Aug; 51(4):2150-2158. PubMed ID: 33705643
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections.
Isnard C; Dhalluin A; Malandain D; Bruey Q; Auzou M; Michon J; Giard JC; Guérin F; Cattoir V
J Glob Antimicrob Resist; 2018 Jun; 13():221-225. PubMed ID: 29421316
[TBL] [Abstract][Full Text] [Related]
18. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
Jones ME
Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
Miranda-Novales G; Leaños-Miranda BE; Vilchis-Pérez M; Solórzano-Santos F
Ann Clin Microbiol Antimicrob; 2006 Oct; 5():25. PubMed ID: 17034644
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of synergy between SIPI-8294 and β-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
He M; Shao L; Liu Q; Li J; Lin H; Jing L; Li M; Chen D
Lett Appl Microbiol; 2016 Jul; 63(1):3-10. PubMed ID: 27173151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
